CF
48
-3
PGR
60
-2
XYL
52
5
AVGO
66
3
OXY
40
2
XEL
67
2
TSCO
48
2
USB
66
12
WMB
59
3
APH
83
2
UHS
64
2
CHD
32
-3
SO
71
-2
IVZ
40
4
LUV
56
4
RHI
27
3
DFS
68
4
VZ
55
3
RCL
85
4
UAL
50
7
CF
48
-3
PGR
60
-2
XYL
52
5
AVGO
66
3
OXY
40
2
XEL
67
2
TSCO
48
2
USB
66
12
WMB
59
3
APH
83
2
UHS
64
2
CHD
32
-3
SO
71
-2
IVZ
40
4
LUV
56
4
RHI
27
3
DFS
68
4
VZ
55
3
RCL
85
4
UAL
50
7
Financhill
Back

Myriad Genetics 10K Form

Sell
28

MYGN
Myriad Genetics

Last Price:
$7.56
Seasonality Move:
4.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q MYGN/Myriad Genetics Quarterly
2023-11-07 10Q MYGN/Myriad Genetics Quarterly
2023-08-04 10Q MYGN/Myriad Genetics Quarterly
2023-05-04 10Q MYGN/Myriad Genetics Quarterly
2022-11-02 10Q MYGN/Myriad Genetics Quarterly
2022-08-05 10Q MYGN/Myriad Genetics Quarterly

Receive MYGN News And Ratings

See the #1 stock for the next 7 days that we like better than MYGN

MYGN Financial Statistics

Sales & Book Value

Annual Sales: $837.6M
Cash Flow: $700K
Price / Cash Flow: 0
Annual Sales: $7.68
Price / Book: 0.98

Profitability

EPS (TTM): -1.41000
Net Income (TTM): $-127.3M
Gross Margin: $585.4M
Return on Equity: -17.13%
Return on Assets: -11.68%

Myriad Genetics Earnings Forecast

Key Myriad Genetics Financial Ratios

  • The Gross Profit Margin over the past 29 years for MYGN is 69.89%.
  • The Selling, General & Administrative Expenses for MYGN have been equal to 66.86% of Gross Profit Margin.
  • The Research & Development expenses have been 13.54% of Revenue.
  • The Net Earning history of MYGN is -15.20% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Myriad Genetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MYGN
CUSIP: 62855J
Website: myriad.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 1.82
Quick Ratio: 1.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 27.75

MYGN Technical Analysis vs Fundamental Analysis

Sell
28
Myriad Genetics (MYGN) is a Sell

Is Myriad Genetics a Buy or a Sell?

  • Myriad Genetics stock is rated a Sell
    The current Myriad Genetics [MYGN] share price is $7.56. The Score for MYGN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.